20 (AIDX) Net Cash Flow (2025 - 2026)
20's (AIDX) quarterly Net Cash Flow came in at $3.2 million in Q1 2026, up 1513.16% YoY from $197941.1 in Q1 2025, and up 1513.16% on a QoQ basis from -$225955.0 in Q1 2025.
20 (AIDX) Net Cash Flow (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Net Cash Flow data on file, last reported at $3.2 million in Q1 2026.
- Quarterly Net Cash Flow rose 1513.16% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (changed N/A YoY) and the FY2025 annual result came in at -$758022.0, up 67.12% from the prior year.
- Net Cash Flow improved to $3.2 million in Q1 2026, from -$225955.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $3.2 million in Q1 2026 to a low of -$225955.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 45.10 Mn |
| 10 | 20 | 5.55 Mn | 1.00 Mn | 304,727.00 | 327,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.19 Mn |
| Mar 31, 2026 | 3.19 Mn |
| Mar 31, 2025 | -225,955.00 |
| Mar 31, 2025 | -225,955.00 |